Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Guided ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem-cell Transplantation

NCT07791576 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT07791576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Guided ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem-cell Transplantation
Lead sponsor
Chinese PLA General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 10, 2025
Completion date
December 30, 2027
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation